Correlation Between Pfizer and Chugai Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Pfizer and Chugai Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Chugai Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Chugai Pharmaceutical Co, you can compare the effects of market volatilities on Pfizer and Chugai Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Chugai Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Chugai Pharmaceutical.
Diversification Opportunities for Pfizer and Chugai Pharmaceutical
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pfizer and Chugai is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Chugai Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chugai Pharmaceutical and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Chugai Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chugai Pharmaceutical has no effect on the direction of Pfizer i.e., Pfizer and Chugai Pharmaceutical go up and down completely randomly.
Pair Corralation between Pfizer and Chugai Pharmaceutical
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Chugai Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.28 times less risky than Chugai Pharmaceutical. The stock trades about -0.07 of its potential returns per unit of risk. The Chugai Pharmaceutical Co is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1,297 in Chugai Pharmaceutical Co on August 27, 2024 and sell it today you would earn a total of 733.00 from holding Chugai Pharmaceutical Co or generate 56.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Chugai Pharmaceutical Co
Performance |
| Timeline |
| Pfizer Inc |
| Chugai Pharmaceutical |
Pfizer and Chugai Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Chugai Pharmaceutical
The main advantage of trading using opposite Pfizer and Chugai Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Chugai Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will offset losses from the drop in Chugai Pharmaceutical's long position.| Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
| Chugai Pharmaceutical vs. Scilex Holding | Chugai Pharmaceutical vs. Merck Company | Chugai Pharmaceutical vs. Johnson Johnson | Chugai Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |